Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 15;23(1):568.
doi: 10.1186/s13063-022-06485-5.

Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy

Jantine Geertruida Röttgering  1   2   3 , Linda Douw  4   5   6 , Philip C de Witt Hamer  4   7 , Mathilde C M Kouwenhoven  4   8 , Tom Würdinger  4   7 , Peter M van de Ven  9 , Louise Sharpe  10 , Hans Knoop  11   12   13 , Martin Klein  11   4
Affiliations

Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy

Jantine Geertruida Röttgering et al. Trials. .

Abstract

Background: Fatigue is the most frequent and burdensome symptom of patients with diffuse glioma. It is closely linked to decreased health-related quality of life and symptoms such as depression and sleep disturbances. Currently, there is no evidence-based treatment that targets severe fatigue in patients with brain tumours. Cognitive behavioural therapy is aimed at fatigue-maintaining beliefs and behaviour. This therapy has been proven effective in reducing severe fatigue in cancer survivors and patients with multiple sclerosis. A blended therapy program combines sessions with a therapist with therapist-guided web-based therapy modules. The aim of this randomized controlled trial is to determine the efficacy of blended cognitive behavioural therapy in treating severe fatigue in patients with diffuse glioma.

Methods: We will include a maximum of 100 patients with diffuse glioma with clinically and radiologically stable disease and severe fatigue (i.e. Checklist Individual Strength, subscale fatigue severity ≥ 35). Patients will be randomized to blended cognitive behavioural therapy or a waiting list condition. The 12-week intervention GRIP on fatigue consists of five patient-therapist sessions and five to eight individualized web-based therapy modules supported by email contact. The primary outcome measure is fatigue severity. Secondary outcome measures include sleep quality, health-related quality of life, depression, anxiety, functional impairment and subjective and objective cognitive functioning. Primary and secondary outcome measures will be assessed at baseline and after 14 and 24 weeks. Magnetoencephalography and MRI will be used to evaluate potential biomarkers for intervention success. This trial has a Bayesian design: we will conduct multiple interim analyses to test for efficacy or futility of the trial. This is the first trial within the GRIP trial platform: a platform developing four to five different interventions for the most common symptoms in patients with diffuse glioma.

Discussion: The results of the GRIP on fatigue trial will provide information about the efficacy of this intervention on fatigue in patients with diffuse glioma. Multiple other outcomes and possible predictors of treatment success will also be explored.

Trial registration: Netherlands Trial Register NL8711 . Registered on 14 June 2020.

Keywords: Blended cognitive behavioural therapy; Cancer; Digital health; Fatigue; Glioma; Health-related quality of life; Online intervention; Psychosocial intervention; Web-based.

PubMed Disclaimer

Conflict of interest statement

This trial is funded by the Stichting Anita Veldman Foundation. The authors declare that they have no other competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of the trial
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. National Working group on Neuro-Oncology (LWNO). Richtlijn gliomen. 2015. [cited 2019 December 22] https://richtlijnendatabase.nl/richtlijn/gliomen/gliomen_-_startpagina.html.
    1. Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3(3):159–168. doi: 10.1016/S1474-4422(04)00680-5. - DOI - PubMed
    1. Boele FW, Klein M, Reijneveld JC, Verdonck-de Leeuw IM, Heimans JJ. Symptom management and quality of life in glioma patients. CNS Oncol. 2014;3(1):37–47. doi: 10.2217/cns.13.65. - DOI - PMC - PubMed
    1. Taphoorn MJ, Sizoo EM, Bottomley A. Review on quality of life issues in patients with primary brain tumors. Oncologist. 2010;15(6):618–626. doi: 10.1634/theoncologist.2009-0291. - DOI - PMC - PubMed
    1. Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F, et al. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. Ann Oncol Off J Eur Soc Med Oncol. 2020;31(6):713–723. doi: 10.1016/j.annonc.2020.02.016. - DOI - PubMed

Publication types

LinkOut - more resources